Back to User profile » Dr Alvin Stein
Papers published by Dr Alvin Stein:
Parkinson’s Disease-Associated Melanin Steal [Retraction]
Hinz M, Stein A, Cole T
Neuropsychiatric Disease and Treatment 2021, 17:733-734
Published Date: 3 March 2021
Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2021, 13:43-44
Published Date: 3 March 2021
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Retraction]
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2021, 13:41-42
Published Date: 3 March 2021
Administration of Supplemental L-Tyrosine with Phenelzine: a Clinical Literature Review [Retraction]
Hinz M, Stein A, Cole T, Ryan P
Clinical Pharmacology: Advances and Applications 2021, 13:39-40
Published Date: 3 March 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
5-HTP Efficacy and Contraindications [Retraction]
Hinz M, Stein A, Uncini T
Neuropsychiatric Disease and Treatment 2021, 17:731-732
Published Date: 3 March 2021
Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Retraction]
Hinz M, Stein A, Uncini T
International Journal of Nephrology and Renovascular Disease 2021, 14:65-66
Published Date: 3 March 2021
Monoamine Depletion by Reuptake Inhibitors [Retraction]
Hinz M, Stein A, Uncini T
Drug, Healthcare and Patient Safety 2020, 12:269-270
Published Date: 16 December 2020
The Discrediting of the Monoamine Hypothesis [Retraction]
Hinz M, Stein A, Uncini T
International Journal of General Medicine 2020, 13:1547-1548
Published Date: 16 December 2020
Amino Acid-Responsive Crohn’s Disease: A Case Study [Retraction]
Stein A, Hinz M, Uncini T
Clinical and Experimental Gastroenterology 2020, 13:589-590
Published Date: 16 December 2020
A Pilot Study Differentiating Recurrent Major Depression from Bipolar Disorder Cycling on the Depressive Pole [Retraction]
Hinz M, Stein A, Uncini T
Neuropsychiatric Disease and Treatment 2020, 16:3129-3130
Published Date: 16 December 2020
The Dual-Gate Lumen Model of Renal Monoamine Transport [Retraction]
Hinz M, Stein A, Uncini T
Neuropsychiatric Disease and Treatment 2020, 16:3133-3134
Published Date: 16 December 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Amino Acid Management of Parkinson’s Disease: a Case Study [Retraction]
Hinz M, Stein A, Uncini T
International Journal of General Medicine 2020, 13:1545-1546
Published Date: 16 December 2020
Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Retraction]
Hinz M, Stein A, Uncini T
Research and Reports in Urology 2020, 12:659-660
Published Date: 16 December 2020
Neurotransmitter Testing of the Urine: a Comprehensive Analysis [Retraction]
Hinz M, Stein A, Trachte G, Uncini T
Research and Reports in Urology 2020, 12:661-662
Published Date: 16 December 2020
Management of L-Dopa Overdose in the Competitive Inhibition State [Retraction]
Hinz M, Stein A, Cole T
Drug, Healthcare and Patient Safety 2020, 12:271-272
Published Date: 16 December 2020
Relative Nutritional Deficiencies Associated with Centrally Acting Monoamines [Retraction]
Hinz M, Stein A, Uncini T
International Journal of General Medicine 2020, 13:1549-1550
Published Date: 16 December 2020
APRESS: Apical Regulatory Super System, Serotonin, and Dopamine Interaction [Retraction]
Hinz M, Stein A, Uncini T
Neuropsychiatric Disease and Treatment 2020, 16:3123-3124
Published Date: 16 December 2020
Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Retraction]
Hinz M, Stein A, Neff R, Weinberg R, Uncini T
Neuropsychiatric Disease and Treatment 2020, 16:3131-3132
Published Date: 16 December 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Parkinson’s Disease-Associated Melanin Steal [Expression of Concern]
Hinz M, Stein A, Cole T
Neuropsychiatric Disease and Treatment 2020, 16:1063-1064
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Expression of Concern]
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2020, 12:45-46
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern]
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2020, 12:43-44
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Management of L-Dopa Overdose in the Competitive Inhibition State [Expression of Concern]
Hinz M, Stein A, Cole T
Drug, Healthcare and Patient Safety 2020, 12:59-60
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
APRESS: Apical Regulatory Super System, Serotonin and Dopamine Interaction [Expression of Concern]
Hinz M, Stein A, Uncini T
Neuropsychiatric Disease and Treatment 2020, 16:1071-1072
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Administration of Supplemental L-Tyrosine with Phenelzine: A Clinical Literature Review [Expression of Concern]
Hinz M, Stein A, Cole T, Ryan P
Clinical Pharmacology: Advances and Applications 2020, 12:47-48
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
5-HTP Efficacy and Contraindications [Expression of Concern]
Hinz M, Stein A, Uncini T
Neuropsychiatric Disease and Treatment 2020, 16:1059-1060
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Relative Nutritional Deficiencies Associated with Centrally Acting Monoamines [Expression of Concern]
Hinz M, Stein A, Uncini T
International Journal of General Medicine 2020, 13:143-144
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The Discrediting of the Monoamine Hypothesis [Expression of Concern]
Hinz M, Stein A, Uncini T
International Journal of General Medicine 2020, 13:141-142
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Monoamine Depletion by Reuptake Inhibitors [Expression of Concern]
Hinz M, Stein A, Uncini T
Drug, Healthcare and Patient Safety 2020, 12:57-58
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Expression of Concern]
Hinz M, Stein A, Uncini T
International Journal of Nephrology and Renovascular Disease 2020, 13:73-74
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Expression of Concern]
Hinz M, Stein A, Uncini T
Research and Reports in Urology 2020, 12:145-146
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Amino Acid Management of Parkinson’s Disease: A Case Study [Expression of Concern]
Hinz M, Stein A, Uncini T
International Journal of General Medicine 2020, 13:145-146
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Treatment of Attention Deficit Hyperactivity Disorder with Monoamine Amino Acid Precursors and Organic Cation Transporter Assay Interpretation [Expression of Concern]
Hinz M, Stein A, Neff R, Weinberg R, Uncini T
Neuropsychiatric Disease and Treatment 2020, 16:1067-1068
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Amino Acid-Responsive Crohn’s Disease: A Case Study [Expression of Concern]
Stein A, Hinz M, Uncini T
Clinical and Experimental Gastroenterology 2020, 13:105-106
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A Pilot Study Differentiating Recurrent Major Depression from Bipolar Disorder Cycling on the Depressive Pole [Expression of Concern]
Hinz M, Stein A, Uncini T
Neuropsychiatric Disease and Treatment 2020, 16:1065-1066
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Neurotransmitter Testing of the Urine: A Comprehensive Analysis [Expression of Concern]
Hinz M, Stein A, Trachte G, Uncini T
Research and Reports in Urology 2020, 12:147-148
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The Dual-Gate Lumen Model of Renal Monoamine Transport [Expression of Concern]
Hinz M, Stein A, Uncini T
Neuropsychiatric Disease and Treatment 2020, 16:1085-1086
Published Date: 23 April 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Amino acid management of Parkinson's disease: a case study [Corrigendum]
Hinz M, Stein A, Uncini T
International Journal of General Medicine 2016, 9:205-206
Published Date: 13 June 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Relative nutritional deficiencies associated with centrally acting monoamines [Corrigendum]
Hinz M, Stein A, Uncini T
International Journal of General Medicine 2015, 8:163-164
Published Date: 22 April 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Parkinson’s disease-associated melanin steal
![](cr_data/cache/submission_images/s74000/74952/figure_1_melanin_steal_200_200_90.jpg)
Hinz M, Stein A, Cole T
Neuropsychiatric Disease and Treatment 2014, 10:2331-2337
Published Date: 10 December 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Parkinson's disease: carbidopa, nausea, and dyskinesia
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2014, 6:189-194
Published Date: 14 November 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The Parkinson's disease death rate: carbidopa and vitamin B6
Hinz M, Stein A, Cole T
Clinical Pharmacology: Advances and Applications 2014, 6:161-169
Published Date: 21 October 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Management of L-dopa overdose in the competitive inhibition state
Hinz M, Stein A, Cole T
Drug, Healthcare and Patient Safety 2014, 6:93-99
Published Date: 22 July 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Administration of supplemental L-tyrosine with phenelzine: a clinical literature review
Hinz M, Stein A, Cole T, Ryan P
Clinical Pharmacology: Advances and Applications 2014, 6:107-110
Published Date: 22 July 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
5-HTP efficacy and contraindications
Hinz M, Stein A, Uncini T
Neuropsychiatric Disease and Treatment 2012, 8:323-328
Published Date: 19 July 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Relative nutritional deficiencies associated with centrally acting monoamines
Hinz M, Stein A, Uncini T
International Journal of General Medicine 2012, 5:413-430
Published Date: 8 May 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The discrediting of the monoamine hypothesis
Hinz M, Stein A, Uncini T
International Journal of General Medicine 2012, 5:135-142
Published Date: 14 February 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Monoamine depletion by reuptake inhibitors
Hinz M, Stein A, Uncini T
Drug, Healthcare and Patient Safety 2011, 3:69-77
Published Date: 20 October 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
APRESS: apical regulatory super system, serotonin, and dopamine interaction
Hinz M, Stein A, Uncini T
Neuropsychiatric Disease and Treatment 2011, 7:457-463
Published Date: 5 August 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Validity of urinary monoamine assay sales under the “spot baseline urinary neurotransmitter testing marketing model”
Hinz M, Stein A, Uncini T
International Journal of Nephrology and Renovascular Disease 2011, 4:101-113
Published Date: 20 July 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Microperforation prolotherapy: a novel method for successful nonsurgical treatment of atraumatic spontaneous anterior sternoclavicular subluxation, with an illustrative case
Stein A, McAleer S, Hinz M
Open Access Journal of Sports Medicine 2011, 2:47-52
Published Date: 7 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine
Marty Hinz, Alvin Stein, Thomas Uncini
Research and Reports in Urology 2011, 3:19-24
Published Date: 4 February 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation
Marty Hinz, Alvin Stein, Robert Neff, et al
Neuropsychiatric Disease and Treatment 2011, 7:31-38
Published Date: 26 January 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Amino acid-responsive Crohn's disease: a case study
Alvin Stein, Marty Hinz, Thomas Uncini
Clinical and Experimental Gastroenterology 2010, 3:171-177
Published Date: 6 December 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
Marty Hinz, Alvin Stein, Thomas Uncini
Neuropsychiatric Disease and Treatment 2010, 6:741-747
Published Date: 9 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Neurotransmitter testing of the urine: a comprehensive analysis
Marty Hinz, Alvin Stein, George Trachte, et al
Research and Reports in Urology 2010, 2:177-183
Published Date: 7 October 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The dual-gate lumen model of renal monoamine transport
Marty Hinz, Alvin Stein, Thomas Uncini
Neuropsychiatric Disease and Treatment 2010, 6:387-392
Published Date: 5 July 2010